14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
OHI vs NHI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
NHI Captures Overall Composite Edge (26.3 SELL vs 50.5 HOLD), While OHI Leads 5–1 on Growth & Valuation Pillars
NHI Overall Winner
6-Pillar Tally: OHI 5 – 1 NHI
Matrix Metrics: OHI 5 – 5 NHI
As of Nov 16, 2026, National Health Investors (NHI) captures the overall head-to-head institutional edge over Omega Healthcare Investors Inc. (OHI) on higher Unified Composite conviction (26.3/100 SELL vs. 50.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while OHI wins 5–1 across the 6-pillar growth and valuation breakdown. OHI trades at $46.91 (22.6x Forward P/E, 62.6% operating margin) versus NHI at $61.97 (18.2x Forward P/E, 42.5% operating margin).
Composite vs. Pillar Nuance: While OHI currently prints a higher short-term Unified Composite Score (50.5/100 HOLD vs. NHI 26.3/100 SELL), NHI captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (42.5% vs. 62.6% operating margin) and revenue trajectory (+26.3% vs. -0.6% YoY).
Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OHI vs NHI. Trailing 12-month operating profitability (OHI 62.6% vs NHI 42.5%) and valuation multiples (OHI 22.6x vs NHI 18.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the REIT - Healthcare Facilities value chain with $15.0B market capitalization and 62.6% operating margin.
OpEx & R&D Reinvestment33.2% of Rev ($418M)
90D Engineering Disclosures0 Published
NHI Moat ProfileHigh-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.2B market capitalization and 42.5% operating margin.
OpEx & R&D Reinvestment28.7% of Rev ($132M)
90D Engineering Disclosures0 Published
Investor FAQ OHI vs NHI Key Questions & Quantitative Answers
As of Nov 16, 2026, National Health Investors (NHI) captures the overall head-to-head institutional edge over Omega Healthcare Investors Inc. (OHI) on higher Unified Composite conviction (26.3/100 SELL vs. 50.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while OHI wins 5–1 across the 6-pillar growth and valuation breakdown. OHI trades at $46.91 (22.6x Forward P/E, 62.6% operating margin) versus NHI at $61.97 (18.2x Forward P/E, 42.5% operating margin). Composite vs. Pillar Nuance: While OHI currently prints a higher short-term Unified Composite Score (50.5/100 HOLD vs. NHI 26.3/100 SELL), NHI captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (42.5% vs. 62.6% operating margin) and revenue trajectory (+26.3% vs. -0.6% YoY). Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
OHI leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with NHI at +26.3% YoY revenue growth and N/A YoY earnings growth on $459M TTM revenue (71.2% gross margin, 42.5% operating margin). On trailing 12-month operating scale, OHI generates $1.26B in USD-normalized revenue versus $459M for NHI. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 28.7% of Rev ($132M) (0 disclosures) for NHI.
NHI screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas NHI trades at 18.2x Forward P/E, 4.6x Trailing P/E, 4.76x PEG, and 6.9x EV/Revenue (63.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus NHI (38.6% ROE) capital efficiency.
In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, NHI carries 19.1% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.21β · 34% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.